Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Simões BP[au]:

Search results

Items: 1 to 50 of 104

1.

Mobilisation and harvesting of haematopoietic progenitor cell in autoimmune diseases.

De Santis GC, Dotoli GM, de Pina Almeida Prado B Jr, de Moraes DA, Elias Dias JB, Simões BP, Covas DT, Oliveira MC.

Transfus Apher Sci. 2019 Nov 25:102680. doi: 10.1016/j.transci.2019.102680. [Epub ahead of print] No abstract available.

PMID:
31787483
2.

Hematopoietic Stem Cell Transplantation Improves Functional Outcomes of Systemic Sclerosis Patients.

Costa-Pereira KR, Guimarães AL, Moraes DA, Dias JBE, Garcia JT, de Oliveira-Cardoso EA, Zombrilli A, Leopoldo V, Costa TM, Simões BP, Oliveira MC.

J Clin Rheumatol. 2019 Aug 6. doi: 10.1097/RHU.0000000000001117. [Epub ahead of print]

PMID:
31397762
3.

IGF1R/IRS1 targeting has cytotoxic activity and inhibits PI3K/AKT/mTOR and MAPK signaling in acute lymphoblastic leukemia cells.

Rodrigues Alves APN, Fernandes JC, Fenerich BA, Coelho-Silva JL, Scheucher PS, Simões BP, Rego EM, Ridley AJ, Machado-Neto JA, Traina F.

Cancer Lett. 2019 Aug 1;456:59-68. doi: 10.1016/j.canlet.2019.04.030. Epub 2019 Apr 28.

PMID:
31042587
4.

A Novel Severity Score Index for Febrile Neutropenic Patients with Colorectal Diseases.

Perazzoli C, Parra RS, Feitosa MR, Sfoggia E, Simões BP, Rocha JJR, Féres O.

Gastroenterol Res Pract. 2019 Mar 24;2019:4175960. doi: 10.1155/2019/4175960. eCollection 2019.

5.

Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease.

Cappelli B, Volt F, Tozatto-Maio K, Scigliuolo GM, Ferster A, Dupont S, Simões BP, Al-Seraihy A, Aljurf MD, Almohareb F, Belendez C, Matthes S, Dhedin N, Pondarre C, Dalle JH, Bertrand Y, Vannier JP, Kuentz M, Lutz P, Michel G, Rafii H, Neven B, Zecca M, Bader P, Cavazzana M, Labopin M, Locatelli F, Magnani A, Ruggeri A, Rocha V, Bernaudin F, de La Fuente J, Corbacioglu S, Gluckman E; Eurocord, the Cellular Therapy and Immunobiology Working Party (CTIWP) and the Paediatric Diseases Working Party (PDWP) of the EBMT.

Haematologica. 2019 Dec;104(12):e543-e546. doi: 10.3324/haematol.2019.216788. Epub 2019 Apr 24. No abstract available.

6.

Impact of early detection of acute invasive fungal rhinosinusitis in immunocompromised patients.

Silveira MLC, Anselmo-Lima WT, Faria FM, Queiroz DLC, Nogueira RL, Leite MGJ, Lessa RM, Simões BP, Tamashiro E, Valera FCP.

BMC Infect Dis. 2019 Apr 5;19(1):310. doi: 10.1186/s12879-019-3938-y.

7.

A Toll-like receptor 2 genetic variant modulates occurrence of bacterial infections in patients with sickle cell disease.

Tozatto-Maio K, Girot R, Ly ID, Rocha V, Silva Pinto AC, Diagne I, Benzerara Y, Dinardo CL, Kashima S, Leston-Araujo I, Kenzey C, Fonseca GHH, Rodrigues ES, Volt F, Jarduli LR, Ruggeri A, Mariaselvam CM, Gualandro SFM, Elayoubi H, Cunha R, Cappelli B, Malmegrim KCR, Simões BP, Gluckman E, Tamouza R.

Br J Haematol. 2019 Jun;185(5):918-924. doi: 10.1111/bjh.15875. Epub 2019 Mar 25.

PMID:
30908604
8.

Mobilizing hematopoietic progenitor cells in donors with sickle cell trait is safe.

De Santis GC, Prado BPA Jr, Dotoli GM, Simões BP, Covas DT.

Hematol Transfus Cell Ther. 2019 Jan-Mar;41(1):101-102. doi: 10.1016/j.htct.2018.04.003. Epub 2018 May 25. No abstract available.

9.

Emerging Aspects of the Body Composition, Bone Marrow Adipose Tissue and Skeletal Phenotypes in Type 1 Diabetes Mellitus.

Carvalho AL, Massaro B, Silva LTPE, Salmon CEG, Fukada SY, Nogueira-Barbosa MH, Elias J Jr, Freitas MCF, Couri CEB, Oliveira MC, Simões BP, Rosen CJ, de Paula FJA.

J Clin Densitom. 2019 Jul - Sep;22(3):420-428. doi: 10.1016/j.jocd.2018.06.007. Epub 2018 Jul 5.

PMID:
30100221
10.

Crosstalk between BCR-ABL and protease-activated receptor 1 (PAR1) suggests a novel target in chronic myeloid leukemia.

Borges CS, Ferreira AF, Almeida VH, Gomes FG, Berzoti-Coelho MG, Cacemiro MDC, Nunes NS, Figueiredo-Pontes LL, Simões BP, Castro FA, Monteiro RQ.

Exp Hematol. 2018 Oct;66:50-62. doi: 10.1016/j.exphem.2018.07.008. Epub 2018 Aug 1.

PMID:
30076949
11.

Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation.

Cacemiro MDC, Cominal JG, Tognon R, Nunes NS, Simões BP, Figueiredo-Pontes LL, Catto LFB, Traina F, Souto EX, Zambuzi FA, Frantz FG, Castro FA.

Hematol Transfus Cell Ther. 2018 Apr-Jun;40(2):120-131. doi: 10.1016/j.htct.2017.12.003. Epub 2018 Feb 17.

12.

Homeostatic proliferation leads to telomere attrition and increased PD-1 expression after autologous hematopoietic SCT for systemic sclerosis.

Arruda LCM, Lima-Júnior JR, Clave E, Moraes DA, Douay C, Fournier I, Moins-Teisserenc H, Covas DT, Simões BP, Farge D, Toubert A, Malmegrim KCR, Oliveira MC.

Bone Marrow Transplant. 2018 Oct;53(10):1319-1327. doi: 10.1038/s41409-018-0162-0. Epub 2018 Apr 18.

PMID:
29670207
13.

MLL2/KMT2D and MLL3/KMT2C expression correlates with disease progression and response to imatinib mesylate in chronic myeloid leukemia.

Rabello DDA, Ferreira VDDS, Berzoti-Coelho MG, Burin SM, Magro CL, Cacemiro MDC, Simões BP, Saldanha-Araujo F, de Castro FA, Pittella-Silva F.

Cancer Cell Int. 2018 Feb 20;18:26. doi: 10.1186/s12935-018-0523-1. eCollection 2018.

14.

Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms.

Machado-Neto JA, Fenerich BA, Scopim-Ribeiro R, Eide CA, Coelho-Silva JL, Dechandt CRP, Fernandes JC, Rodrigues Alves APN, Scheucher PS, Simões BP, Alberici LC, de Figueiredo Pontes LL, Tognon CE, Druker BJ, Rego EM, Traina F.

Cell Death Dis. 2018 Feb 22;9(3):311. doi: 10.1038/s41419-017-0256-4.

15.

Expression of Hippo signaling pathway and Aurora kinase genes in chronic myeloid leukemia.

Marsola APZC, Simões BP, Palma LC, Berzoti-Coelho MG, Burin SM, de Castro FA.

Med Oncol. 2018 Jan 31;35(3):26. doi: 10.1007/s12032-018-1079-6.

PMID:
29387948
16.

Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients.

Arruda LCM, Malmegrim KCR, Lima-Júnior JR, Clave E, Dias JBE, Moraes DA, Douay C, Fournier I, Moins-Teisserenc H, Alberdi AJ, Covas DT, Simões BP, Lansiaux P, Toubert A, Oliveira MC.

Blood Adv. 2018 Jan 23;2(2):126-141. doi: 10.1182/bloodadvances.2017011072.

17.

Zika and chikungunya virus infections in hematopoietic stem cell transplant recipients and oncohematological patients.

Machado CM, Pereira BBS, Felix AC, Oliveira MC, Darrigo LG Jr, de Souza MP, Paton EJA, Neves F, Colturato VR, Simoes BP.

Blood Adv. 2017 Apr 10;1(10):624-627. doi: 10.1182/bloodadvances.2016003285. eCollection 2017 Apr 11.

18.

Microvascular Complications in Type 1 Diabetes: A Comparative Analysis of Patients Treated with Autologous Nonmyeloablative Hematopoietic Stem-Cell Transplantation and Conventional Medical Therapy.

Penaforte-Saboia JG, Montenegro RM Jr, Couri CE, Batista LA, Montenegro APDR, Fernandes VO, Akhtar H, Negrato CA, Malmegrim KCR, Moraes DA, Dias JBE, Simões BP, Gomes MB, Oliveira MC.

Front Endocrinol (Lausanne). 2017 Nov 23;8:331. doi: 10.3389/fendo.2017.00331. eCollection 2017.

19.

Acute myeloid leukemia with e1a2 BCR-ABL1 fusion gene: two cases with peculiar molecular and clinical presentations.

da Silva FB, Machado-Neto JA, Koury LCA, Bertini VHLL, Ratis CA, Chauffaille MLLF, Velloso EDRP, Simões BP, Rego EM, Traina F.

Rev Bras Hematol Hemoter. 2017 Oct - Dec;39(4):379-384. doi: 10.1016/j.bjhh.2017.07.001. Epub 2017 Aug 3. No abstract available.

20.

Serum Cyclosporine Levels: The Influence of the Time Interval Between Interrupting the Infusion and Obtaining the Samples: A Randomized Clinical Trial.

Garbin LM, Simões BP, Curcioli ACJV, de Carvalho EC.

Cancer Nurs. 2018 Jul/Aug;41(4):E55-E61. doi: 10.1097/NCC.0000000000000544.

PMID:
29049039
21.

Paclitaxel induces Stathmin 1 phosphorylation, microtubule stability and apoptosis in acute lymphoblastic leukemia cells.

Machado-Neto JA, Rodrigues Alves APN, Fernandes JC, Coelho-Silva JL, Scopim-Ribeiro R, Fenerich BA, da Silva FB, Scheucher PS, Simões BP, Rego EM, Traina F.

Heliyon. 2017 Sep 28;3(9):e00405. doi: 10.1016/j.heliyon.2017.e00405. eCollection 2017 Sep.

22.

Corrigendum to "The expression of Death Inducer-Obliterator (DIDO) variants in Myeloproliferative Neoplasms" [Blood Cells Mol. Dis. 59 (2016) 25-30].

Berzoti-Coelho MG, Ferreira AF, de Souza Nunes N, Tomazini Pinto M, Júnior MCR, Simões BP, Martínez-A C, Souto EX, Panepucci RA, Covas DT, Kashima S, Castro FA.

Blood Cells Mol Dis. 2018 Mar;69:123. doi: 10.1016/j.bcmd.2017.08.013. Epub 2017 Sep 4. No abstract available.

PMID:
28882478
23.

Treatment outcomes for Hodgkin lymphoma: First report from the Brazilian Prospective Registry.

Biasoli I, Castro N, Delamain M, Silveira T, Farley J, Simões BP, Solza C, Praxedes M, Baiocchi O, Gaiolla R, Franceschi F, Sola CB, Boquimpani C, Clementino N, Perini G, Pagnano K, Steffenello G, Tabacof J, de Freitas Colli G, Soares A, de Souza C, Chiattone CS, Milito C, Morais JC, Spector N.

Hematol Oncol. 2018 Feb;36(1):189-195. doi: 10.1002/hon.2450. Epub 2017 Jun 23.

PMID:
28643458
24.

Prolonged viremia in dengue virus infection in hematopoietic stem cell transplant recipients and patients with hematological malignancies.

de Souza Pereira BB, Darrigo Junior LG, de Mello Costa TC, Felix AC, Simoes BP, Stracieri AB, da Silva PM, Mauad M, Machado CM.

Transpl Infect Dis. 2017 Aug;19(4). doi: 10.1111/tid.12721. Epub 2017 Jun 26.

PMID:
28475281
25.

Mesenchymal stromal cell infusion to treat steroid-refractory acute GvHD III/IV after hematopoietic stem cell transplantation.

Dotoli GM, De Santis GC, Orellana MD, de Lima Prata K, Caruso SR, Fernandes TR, Rensi Colturato VA, Kondo AT, Hamerschlak N, Simões BP, Covas DT.

Bone Marrow Transplant. 2017 Jun;52(6):859-862. doi: 10.1038/bmt.2017.35. Epub 2017 Mar 13.

PMID:
28287644
26.

Immunological Balance Is Associated with Clinical Outcome after Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes.

Malmegrim KC, de Azevedo JT, Arruda LC, Abreu JR, Couri CE, de Oliveira GL, Palma PV, Scortegagna GT, Stracieri AB, Moraes DA, Dias JB, Pieroni F, Cunha R, Guilherme L, Santos NM, Foss MC, Covas DT, Burt RK, Simões BP, Voltarelli JC, Roep BO, Oliveira MC.

Front Immunol. 2017 Feb 22;8:167. doi: 10.3389/fimmu.2017.00167. eCollection 2017.

27.

Paradoxes of hematology: When the old disappears and the new does not arrive.

Maiolino A, Simões BP, de Castro CG Junior, Covas DT, Dos Santos Fernandes G, Hamerschlak N, Fonseca TC, Colturato V.

Rev Bras Hematol Hemoter. 2017 Jan - Mar;39(1):1-3. doi: 10.1016/j.bjhh.2017.01.001. Epub 2017 Jan 23. No abstract available.

28.

18F-FDG PET/CT/MRI Fusion Images Showing Cranial and Peripheral Nerve Involvement in Neurolymphomatosis.

Trevisan AC, Ribeiro FB, Itikawa EN, Alexandre LS, Pitella FA, Santos AC, Simões BP, Wichert-Ana L.

Indian J Nucl Med. 2017 Jan-Mar;32(1):77-78. doi: 10.4103/0972-3919.198502.

29.

Higher Anti-A/B isoagglutinin titers of IgG class, but not of IgM, are associated with increased red blood cell transfusion requirements in bone marrow transplantation with major ABO-mismatch.

De Santis GC, Garcia-Silva AC, Dotoli GM, de Castro PT, Simões BP, Covas DT.

Clin Transplant. 2017 Apr;31(4). doi: 10.1111/ctr.12913. Epub 2017 Feb 20.

PMID:
28160319
30.

Enantioselectivity in the Metabolism of Cyclophosphamide in Patients With Multiple or Systemic Sclerosis.

de Castro FA, Simões BP, Coelho EB, Lanchote VL.

J Clin Pharmacol. 2017 Jun;57(6):784-795. doi: 10.1002/jcph.863. Epub 2017 Jan 13.

PMID:
28083951
31.

Defective expression of apoptosis-related molecules in multiple sclerosis patients is normalized early after autologous haematopoietic stem cell transplantation.

de Oliveira GL, Ferreira AF, Gasparotto EP, Kashima S, Covas DT, Guerreiro CT, Brum DG, Barreira AA, Voltarelli JC, Simões BP, Oliveira MC, de Castro FA, Malmegrim KC.

Clin Exp Immunol. 2017 Mar;187(3):383-398. doi: 10.1111/cei.12895. Epub 2016 Dec 23.

32.

IRS1/β-Catenin Axis Is Activated and Induces MYC Expression in Acute Lymphoblastic Leukemia Cells.

Fernandes JC, Rodrigues Alves APN, Machado-Neto JA, Scopim-Ribeiro R, Fenerich BA, da Silva FB, Simões BP, Rego EM, Traina F.

J Cell Biochem. 2017 Jul;118(7):1774-1781. doi: 10.1002/jcb.25845. Epub 2017 Mar 15.

PMID:
27987331
33.

Allogenic bone narrow transplantation in sickle-cell diseases.

Simões BP, Pieroni F, Costa T, Barros GN, Darrigo G Jr, Grecco CS, Bernardes JE, Moraes D, Stracieri AB, Cunha R, Rodrigues MC.

Rev Assoc Med Bras (1992). 2016 Oct;62 Suppl 1:16-22.

34.

Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome.

da Silva FB, Machado-Neto JA, Bertini VHLL, Velloso EDRP, Ratis CA, Calado RT, Simões BP, Rego EM, Traina F.

J Clin Pathol. 2017 May;70(5):435-442. doi: 10.1136/jclinpath-2016-204023. Epub 2016 Nov 11.

PMID:
27836923
35.

Reversine triggers mitotic catastrophe and apoptosis in K562 cells.

Rodrigues Alves AP, Machado-Neto JA, Scheucher PS, Paiva HH, Simões BP, Rego EM, Traina F.

Leuk Res. 2016 Sep;48:26-31. doi: 10.1016/j.leukres.2016.06.011. Epub 2016 Jul 1.

PMID:
27447890
36.

Transcriptional profiling reveals intrinsic mRNA alterations in multipotent mesenchymal stromal cells isolated from bone marrow of newly-diagnosed type 1 diabetes patients.

de Lima KA, de Oliveira GL, Yaochite JN, Pinheiro DG, de Azevedo JT, Silva WA Jr, Covas DT, Couri CE, Simões BP, Voltarelli JC, Oliveira MC, Malmegrim KC.

Stem Cell Res Ther. 2016 Jul 12;7(1):92. doi: 10.1186/s13287-016-0351-y.

37.

Different expression patterns of LGALS1 and LGALS3 in polycythemia vera, essential thrombocythemia and primary myelofibrosis.

Moura LG, Tognon R, Nunes NS, Rodrigues LC, Ferreira AF, Kashima S, Covas DT, Santana M, Souto EX, Perobelli L, Simões BP, Dias-Baruffi M, Castro FA.

J Clin Pathol. 2016 Oct;69(10):926-9. doi: 10.1136/jclinpath-2016-203948. Epub 2016 Jul 11.

PMID:
27402956
38.

Immunological correlates of favorable long-term clinical outcome in multiple sclerosis patients after autologous hematopoietic stem cell transplantation.

Arruda LCM, de Azevedo JTC, de Oliveira GLV, Scortegagna GT, Rodrigues ES, Palma PVB, Brum DG, Guerreiro CT, Marques VD, Barreira AA, Covas DT, Simões BP, Voltarelli JC, Oliveira MC, Malmegrim KCR.

Clin Immunol. 2016 Aug;169:47-57. doi: 10.1016/j.clim.2016.06.005. Epub 2016 Jun 16.

PMID:
27318116
39.

The expression of Death Inducer-Obliterator (DIDO) variants in Myeloproliferative Neoplasms.

Berzoti-Coelho MG, Ferreira AF, de Souza Nunes N, Pinto MT, Júnior MC, Simões BP, Martínez-A C, Souto EX, Panepucci RA, Covas DT, Kashima S, Castro FA.

Blood Cells Mol Dis. 2016 Jul;59:25-30. doi: 10.1016/j.bcmd.2016.03.008. Epub 2016 Apr 8. Erratum in: Blood Cells Mol Dis. 2018 Mar;69:123.

PMID:
27282563
40.

Haematological recovery in poor and good haematopoietic stem cell mobilisers.

De Santis GC, Garcia-Silva AC, Chiaramonte NC, Orellana MD, Prado BP Jr, Oliveira LC, Simões BP, Covas DT.

Transfus Med. 2016 Aug;26(4):297-300. doi: 10.1111/tme.12324. Epub 2016 May 30.

PMID:
27237104
41.

Use of an Oral Busulfan Test Dose in Patients Undergoing Hematopoietic Stem Cell Transplantation Treated With or Without Fludarabine.

de Castro FA, Simões BP, Godoy AL, Bertagnoli Trigo FM, Coelho EB, Lanchote VL.

J Clin Pharmacol. 2016 Dec;56(12):1555-1562. doi: 10.1002/jcph.758. Epub 2016 May 20.

PMID:
27130252
42.

Plasma eicosanoid profiles determined by high-performance liquid chromatography coupled with tandem mass spectrometry in stimulated peripheral blood from healthy individuals and sickle cell anemia patients in treatment.

Galvão AF, Petta T, Flamand N, Bollela VR, Silva CL, Jarduli LR, Malmegrim KC, Simões BP, de Moraes LA, Faccioli LH.

Anal Bioanal Chem. 2016 May;408(13):3613-23. doi: 10.1007/s00216-016-9445-8. Epub 2016 Mar 11.

PMID:
26968567
43.

Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties.

Yaochite JN, de Lima KW, Caliari-Oliveira C, Palma PV, Couri CE, Simões BP, Covas DT, Voltarelli JC, Oliveira MC, Donadi EA, Malmegrim KC.

Stem Cell Res Ther. 2016 Jan 18;7:14. doi: 10.1186/s13287-015-0261-4.

44.

Enantioselective analysis of 4-hydroxycyclophosphamide in human plasma with application to a clinical pharmacokinetic study.

de Castro FA, Scatena Gdos S, Rocha OP, Marques MP, Cass QB, Simões BP, Lanchote VL.

J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Feb 1;1011:53-61. doi: 10.1016/j.jchromb.2015.12.049. Epub 2015 Dec 28.

PMID:
26760223
45.

Variation of resting energy expenditure after the first chemotherapy cycle in acute leukemia patients.

Galati PC, Chiarello PG, Simões BP.

Nutr Cancer. 2016;68(1):86-93. doi: 10.1080/01635581.2016.1115100. Epub 2015 Dec 28.

PMID:
26710189
46.

Apoptosis- and cell cycle-related genes methylation profile in myeloproliferative neoplasms.

Tognon R, Nunes NS, Ambrosio L, Souto EX, Perobelli L, Simões BP, Souza MC, Chauffaille Mde L, Attié de Castro F.

Leuk Lymphoma. 2016 May;57(5):1201-4. doi: 10.3109/10428194.2015.1071491. Epub 2015 Oct 5. No abstract available.

PMID:
26437212
47.

Busulfan dosing algorithm and sampling strategy in stem cell transplantation patients.

de Castro FA, Piana C, Simões BP, Lanchote VL, Della Pasqua O.

Br J Clin Pharmacol. 2015 Oct;80(4):618-29. doi: 10.1111/bcp.12648. Epub 2015 Jul 22.

48.

Autologous hematopoietic SCT normalizes miR-16, -155 and -142-3p expression in multiple sclerosis patients.

Arruda LC, Lorenzi JC, Sousa AP, Zanette DL, Palma PV, Panepucci RA, Brum DS, Barreira AA, Covas DT, Simões BP, Silva WA Jr, Oliveira MC, Malmegrim KC.

Bone Marrow Transplant. 2015 Mar;50(3):380-9. doi: 10.1038/bmt.2014.277. Epub 2014 Dec 8.

PMID:
25486582
49.

SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking.

Alexander T, Bondanza A, Muraro PA, Greco R, Saccardi R, Daikeler T, Kazmi M, Hawkey C, Simoes BP, Leblanc K, Fibbe WE, Moore J, Snarski E, Martin T, Hiepe F, Velardi A, Toubert A, Snowden JA, Farge D.

Bone Marrow Transplant. 2015 Feb;50(2):173-80. doi: 10.1038/bmt.2014.251. Epub 2014 Nov 10. Review.

50.

Interaction between IL-6 and TNF-α genotypes associated with bacteremia in multiple myeloma patients submitted to autologous stem cell transplantation (ASCT).

Trigo FM, Luizon MR, Dutra HS, Maiolino A, Nucci M, Simões BP.

Leuk Res Rep. 2014 Sep 1;3(2):76-8. doi: 10.1016/j.lrr.2014.05.002. eCollection 2014.

Supplemental Content

Loading ...
Support Center